Clinical Trial Update: An Open Label Phase 2 Study of Total Neoadjuvant Therapy (TNT) Consisting of FLOT With Pembrolizumab and Short Radiation for Patients With Locally Advanced Gastroesophageal Junction Adenocarcinoma [Phase 2]

View source ↗

Summary

An open-label Phase 2 trial evaluating total neoadjuvant therapy with FLOT chemotherapy plus pembrolizumab and short radiation for locally advanced gastroesopha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Junction Adenocarcinoma

Drugs mentioned

• 5-Fluorouracil (5-FU)
• DOCETAXEL (DOCETAXEL)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: National Cancer Center Hospital East | Conditions: Gastroesophageal Junction (GEJ) Adenocarcinoma | Phase 2 | Status: RECRUITING